Forecasts data is unavailable for this security.
Consensus recommendation
- 15-Jan-26
- 05-Feb-26
Select bar for recommendation details.
| Recommendations | 05-Feb-26 | |
|---|---|---|
| Buy | 0 | |
| Outperform | 1 | |
| Hold | 0 | |
| Sell | 0 | |
| Strong Sell | 0 |
Share price forecast in AUD
The 2 analysts offering 12 month price targets for Cynata Therapeutics Ltd have a median target of 2.49, with a high estimate of 2.99 and a low estimate of 1.99. The median estimate represents a 555.79% increase from the last price of 0.38.
| High | 687.1% | 2.99 |
| Med | 555.8% | 2.49 |
| Low | 424.7% | 1.99 |
Earnings history & estimates in AUD
| Average growth rate | +4.32% |
More ▼
Revenue history & estimates in AUD
| Average growth rate | +71.89% |
More ▼
